We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ATNM market cap is 244.8M. The company's latest EPS is USD -1.7808 and P/E is -5.01.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 45k | 0 | 0 | 0 | 0 |
| Operating Income | -9.8M | -11.29M | -11.58M | -15.64M | -14.35M |
| Net Income | -9.47M | -10.65M | -11.04M | -15.18M | -13.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1.14M | 1.03M | 81k |
| Operating Income | -22.07M | -22.39M | -24.96M | -34.1M | -51.92M |
| Net Income | -21.9M | -22.22M | -24.77M | -33.02M | -48.82M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 116.82M | 114.19M | 102.03M | 99.05M | 88.94M |
| Total Liabilities | 45.56M | 47.71M | 44.82M | 45.97M | 45.36M |
| Total Equity | 71.26M | 66.48M | 57.21M | 53.08M | 43.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.67M | 66.4M | 80.39M | 114.19M | 81.45M |
| Total Liabilities | 6.03M | 5.08M | 6.84M | 47.71M | 45.07M |
| Total Equity | 5.64M | 61.32M | 73.55M | 66.48M | 36.38M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.42M | 8.64M | -15.08M | -28.72M | -39.85M |
| Investing | -350k | -366k | -76k | -123k | -153k |
| Financing | 18.22M | 23.11M | 770k | 10.82M | 13.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.46M | -21.62M | -20.87M | 8.64M | -47.34M |
| Investing | -64k | -253k | -133k | -366k | -153k |
| Financing | 17.11M | 76.18M | 35.22M | 23.11M | 14.87M |
| Market Cap | 244.8M |
| Price to Earnings Ratio | -5.01 |
| Price to Sales Ratio | 2.97k |
| Price to Cash Ratio | 3.19 |
| Price to Book Ratio | 6.72 |
| Dividend Yield | - |
| Shares Outstanding | 27.41M |
| Average Volume (1 week) | 322.1k |
| Average Volume (1 Month) | 317.92k |
| 52 Week Change | -1.11% |
| 52 Week High | 9.8599 |
| 52 Week Low | 4.00 |
| Spread (Intraday) | 0.33 (3.7%) |
| Company Name | Actinium Pharmaceuticals Inc |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://www.actiniumpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
